Health & Fitness
Health and Fitness
Health and Fitness
Mon, February 6, 2012
Sun, February 5, 2012
Sat, February 4, 2012
Fri, February 3, 2012
3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2011 Results
3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2011 Results -- SHENYANG, China, Feb. 3, 2012 /PRNewswire-Asia-FirstCall/ --
3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2011 Results
SHENYANG, China,Feb. 3, 2012 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: [ SSRX ]) ("3SBio"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release its unaudited fourth quarter and full year 2011 results after the NASDAQ stock market closes on Thursday, March 8, 2012 at 8:00pm (US Eastern).
Following the earnings announcement, 3SBio's senior management will host a conference call on Monday, March 12, 2012 at 5:00am (US Pacific) / 8:00am (US Eastern) / 9:00pm (Beijing) to discuss its unaudited fourth quarter and full year 2011 results and recent business activity. The conference call may be accessed using the dial-in numbers below:
Conference ID: 50023809
Local dial-in:
China landline: 800-819-0121
China mobile: 400-620-8038
Hong Kong : 852-2475-0994
United States: 718-354-1231
International toll-free dial-in:
Hong Kong: 800930346
United States: 1-866-519-4004
United Kingdom: 080-8234-6646
International toll dial-in: 65 6723 9381
Replay- Conference ID: 50023809
A telephone replay will be available two hours after the call until March 17, 2012 at:
International: 61-2-8235-5000
United States: 1-866-214-5335
Webcast
A live webcast of the conference will be available on the investor relations section of 3SBio's website at [ www.3sbio.com ] and at [ http://www.media-server.com/m/p/4jjxyoq7 ].
A replay of the webcast will be available within one hour after the conclusion of the call.
About 3SBio Inc.
3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see [ www.3SBio.com ] for more information.
Investor Contacts
Bo Tan
Chief Financial Officer
3SBio Inc.
Tel: + 86 24 2581-1820
[ ir@3SBio.com ]
Tom Folinsbee
Director of Investor Relations
3SBio Inc.
Tel: + 852 8191-6991
[ ir@3SBio.com ]
SOURCE 3SBio Inc.
[ Back to top ] RELATED LINKS
[ http://www.3sbio.com ]
